AnxA1 expression is increased in intestinal tissue of ulcerative colitis patients while decreased in Crohn's disease patients, evidencing these diseases deregulate AnxA1 actions leading to compromised anti-inflammatory responses (Vong et al., 2012; Sena et al., 2013). The gene discussed is ANXA1; the disease is ulcerative colitis.